Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 3Thoracic 1Other hematologic neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Rectal Neoplasms 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Lung Neoplasms 5Leukemia, Myeloid, Acute 5Leukemia 5Colonic Neoplasms 5Multiple Myeloma 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Immunoblastic Lymphadenopathy 4Colorectal Neoplasms 4Burkitt Lymphoma 4Waldenstrom Macroglobulinemia 3Stomach Neoplasms 3Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Non-Hodgkin 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Esophageal Neoplasms 3Congenital Abnormalities 3

Interventions

Rituximab 173Cyclophosphamide 156Vincristine 72fludarabine phosphate 71Etoposide 68Doxorubicin 68Prednisone 66Filgrastim 58Methotrexate 52Cytarabine 51fludarabine 49Melphalan 48Busulfan 47Tacrolimus 41Whole-Body Irradiation 39Mycophenolic Acid 39Granulocyte Colony-Stimulating Factor 37Antilymphocyte Serum 31Peripheral Blood Stem Cell Transplantation 30Radiotherapy 27Lenalidomide 25Dexamethasone 25Carmustine 23Stem Cell Transplantation 22Cyclosporine 22Bortezomib 22Gemcitabine 20Bendamustine Hydrochloride 20ibritumomab tiuxetan 19Alemtuzumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Lymphoma × Gene Expression Profiling × Clear all
NCT01567722 2023-03-16

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

AIDS Malignancy Consortium

Terminated
114 enrolled 8 charts
LymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Lymphoma, HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT00691652 2019-11-27

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

OHSU Knight Cancer Institute

Phase 1/2 Terminated
2 enrolled 4 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00851552 2014-07-21

Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

Roswell Park Cancer Institute

Phase 2 Terminated
9 enrolled 5 charts
Lymphoid

Lymphoma, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡